Posted on Friday, May 28th, 2010 at 1:00 pm
The global market for Radio Frequency Identification (RFID) products and services in the pharmaceutical industry was valued at $112m in 2008 and is expected to grow to $884m in 2015 at a CAGR of 34% over the same period. GBI Research’s analysis suggests that the RFID technology is in the early stages of adoption within the pharmaceutical industry. The market for RFID in pharmaceuticals is hampered by low adoption rates due to apprehensions over high investments and the lack of a clear business case. However, solutions for the pharmaceutical industry are evolving to address the concerns responsible for the slow growth.
